Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 9)
HC Wainwright & Co. Maintains Buy on Cytokinetics, Raises Price Target to $58
HC Wainwright & Co. analyst Joseph Pantginis maintains Cytokinetics (NASDAQ:CYTK) with a Buy and raises the price target from $53 to $58.
Cytokinetics: Q2 Earnings Insights
Shares of Cytokinetics (NASDAQ:CYTK) moved lower in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share decreased 26.47% over the past year to ($0.86), which missed the estimate of ($0.65).
Cytokinetics Q2 EPS $(0.86) Misses $(0.65) Estimate, Sales $2.84M Down From $3.59M YoY
Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.65) by 32.31 percent. This is a 26.47 percent decrease over losses of $(0.68) per share from
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Why Cytokinetics (CYTK) Shares Are Trading Higher Today?
Cytokinetics Incorporated (NASDAQ: CYTK) shares continue to move forward after it announced positive REDWOOD-HCM Phase 2 data for CK-274 and garnered
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 19)
10 Biggest Price Target Changes For Tuesday
Citigroup boosted International Business Machines Corporation (NYSE: IBM) price target from $140 to $150. IBM shares rose 4% to $143.41 in pre-market trading.